BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 5970685)

  • 1. Synthesis and pharmacology of N-(4-diethylamino-2-butynyl)-succinimide (DKJ 21), a new central anticholinergic agent.
    Dahlbom R; Karlen B; George R; Jenden DJ
    Life Sci; 1966 Sep; 5(17):1625-31. PubMed ID: 5970685
    [No Abstract]   [Full Text] [Related]  

  • 2. The peripheral and central actions of some anticholinergic substances.
    Brimblecombe RW; Green DM
    Int J Neuropharmacol; 1968 Jan; 7(1):15-21. PubMed ID: 5639303
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacology of a potential anti-Parkinson agent: tigloidine.
    Sanghvi I; Bindler E; Gershon S
    Eur J Pharmacol; 1968 Oct; 4(3):246-53. PubMed ID: 5723419
    [No Abstract]   [Full Text] [Related]  

  • 4. Acetylene compounds of potential pharmacological value. 8. N-(4-dialkylamino-2-butynyl)-substituted cyclic imides.
    Dahlbom R; Karlén B; George R; Jenden DJ
    J Med Chem; 1966 Nov; 9(6):843-6. PubMed ID: 5972043
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of N-(4-diethylamino-2-butynyl)-succinimide (DKJ 21) on oxotremorine induced hypothermia in the rat.
    Kirkpatrick WE; Jenden DJ; Lomax P
    Int J Neuropharmacol; 1967 Jul; 6(4):273-7. PubMed ID: 4382489
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of elantrine, a new anti-Parkinsonism agent, on drug-induced tremor in mice.
    Ursillo RC; McCulloch JA
    Arch Int Pharmacodyn Ther; 1972 May; 197(1):132-40. PubMed ID: 5031571
    [No Abstract]   [Full Text] [Related]  

  • 7. Acetylene compounds of potential pharmacological value. XII. Central and peripheral anticholinergic activity of t-aminoalkynyl esters of some carboxylic acids.
    Dahlbom R; Erbing B; Olsson K; George R; Jenden DJ
    Acta Pharm Suec; 1969 Jun; 6(3):349-58. PubMed ID: 5824849
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of selective central muscarinic blockade on schedule-controlled behavior and on the rate-decreasing effects of physostigmine.
    Hymowitz N; Brezenoff HE
    Pharmacol Biochem Behav; 1984 Jul; 21(1):109-15. PubMed ID: 6463084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parasympatholytic (anticholinergic) esters of the isomeric 2-tropanols. 2. Non-glycolates.
    Atkinson ER; McRitchie-Ticknor DD; Harris LS; Archer S; Aceto MD; Pearl J; Luduena FP
    J Med Chem; 1983 Dec; 26(12):1772-5. PubMed ID: 6644747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the effect of benactyzine and atropine on the conditioned pupillary reflex in cats].
    DOSTALEK C; SCHEER E
    Acta Biol Med Ger; 1962; 8():523-9. PubMed ID: 13887483
    [No Abstract]   [Full Text] [Related]  

  • 11. Acetylene compounds of potential pharmacological value. XIV. N-(t-aminoalkynyl)-substituted succinimides and maleimides. A class of central anticholinergic agents.
    Karlèn B; Lindeke B; Lindgren S; Svensson KG; Dahlbom R; Jenden DJ; Giering JE
    J Med Chem; 1970 Jul; 13(4):651-7. PubMed ID: 5452427
    [No Abstract]   [Full Text] [Related]  

  • 12. Central and peripheral actions of anticholinergic drugs when administered with triflupromazine.
    Brimblecombe RW; Green DM; Aldous FA; Thompson PB
    Neuropharmacology; 1971 Jan; 10(1):93-101. PubMed ID: 5569310
    [No Abstract]   [Full Text] [Related]  

  • 13. Oxybutynin--a musculotropic antispasmodic drug with moderate anticholinergic action.
    Lish PM; Labudde JA; Peters EL; Robbins SI
    Arch Int Pharmacodyn Ther; 1965 Aug; 156(2):467-88. PubMed ID: 4380481
    [No Abstract]   [Full Text] [Related]  

  • 14. Central and peripheral anticholinergic potency of some drugs antagonistic to anticholinesterase poisoning.
    Madill HD; Stewart WC; Savoie ML
    Can J Physiol Pharmacol; 1968 Jul; 46(4):559-65. PubMed ID: 5668200
    [No Abstract]   [Full Text] [Related]  

  • 15. Antagonism of the effects of tremorine by tropine derivatives.
    FARQUHARSON ME; JOHNSTON RG
    Br J Pharmacol Chemother; 1959 Dec; 14(4):559-66. PubMed ID: 13821613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of centrally acting and other drugs against tremor and hypothermia induced in mice by tremorine.
    Spencer PS
    Br J Pharmacol Chemother; 1965 Oct; 25(2):442-55. PubMed ID: 5866724
    [No Abstract]   [Full Text] [Related]  

  • 17. [Central effects of cholinomimetic and cholinolytic substances].
    Holmstedt B
    Actual Pharmacol (Paris); 1970; 23():175-98. PubMed ID: 4948985
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antagonism of the central and peripheral effects of tremorine by 2 parasympatholytics: atropine and scopolamine].
    Fontaine O; Richelle M
    Psychopharmacologia; 1967; 11(2):154-64. PubMed ID: 5588186
    [No Abstract]   [Full Text] [Related]  

  • 19. Central and peripheral effects of anticholinergic compounds.
    Albanus L
    Acta Pharmacol Toxicol (Copenh); 1970; 28(4):305-26. PubMed ID: 5536020
    [No Abstract]   [Full Text] [Related]  

  • 20. N-(t-aminoalkynyl)-substituted pyrrolidones as oxotremorine antagonists.
    Lindgren S; Lindquist A; Lindeke B; Svensson U; Karlén B; Dahlbem R; Blair MR
    Experientia; 1970 Nov; 26(11):1232-3. PubMed ID: 5485292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.